Speaking of Medgate: DPO of Medgate has left a very interesting...

First 26 Last

Share
Profile

Follow
djtrading

424 Posts.

356

11/10/21

21:40

Post #: 56722103
Share

Originally posted by Red bar ↑

Not the news I was hoping for as I'm waiting for more material type announcements with large revenue potential like Alodokter, Medgate ETC, however it is a positive step forward and if approved ResApp's technology for the first time will be utilised in the US which will give us a much better chance of obtaining FDA clearance for our DX medical software that uses no additional hardware to identify coughing signatures.

I am very confident that ResApp's Sleep Apnea technology will be approved as a screening tool by the FDA, especially when one considers that our results are better than Drowzle mobile software application which already has been approved in the United States... I'm also glad that we don't have to splash around anymore funds in order to perform a study on US soil...

This update is welcoming for the screening of sleep apnea although I really don't think it's going to bring in massive amounts of revenue, but it will contribute somewhat to our bottom line and every little bit counts right?! If FDA approval is granted I would expect further uptake or a possible acquisition to a larger player who has plenty of money to splash around to get the word out for people to actually use it, as opposed to our company with limited funds and resources...

Cheers

Red bar

Expand

Speaking of Medgate: DPO of Medgate has left a very interesting comment in LinkedIn to Tony’s post about today’s announcement.

I don’t have to say much here. That’s some endorsement!

link to the post https://www.linkedin.com/posts/tony...mission-for-activity-6853108167505776640-i6Tm

Imo and please Dyor.

RAP Price at posting: 6.8¢ Sentiment: Buy Disclosure: Held
38 Upvote

7 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement